Comments on: FDA Discontinues ESA APPRISE Risk Evaluation and Mitigation Strategy Program

Comments on: FDA Discontinues ESA APPRISE Risk Evaluation and Mitigation Strategy Program https://www.oncologynurseadvisor.com/home/cancer-types/hematologic-cancers/fda-discontinues-esa-apprise-risk-evaluation-and-mitigation-strategy-program/ Mon, 20 May 2019 15:42:48 +0000 hourly 1 https://wordpress.org/?v=6.4.3